Endocrinology, Vol 114, 1099-1107, Copyright © 1984 by Endocrine Society

ARTICLES

Thyrotropin-stimulated iodide transport mediated by adenosine 3',5'- monophosphate and dependent on protein synthesis

SJ Weiss, NJ Philp, FS Ambesi-Impiombato and EF Grollman

Iodide (I-) uptake by FRTL-5 cells, a functioning rat thyroid cell line, is TSH dependent. The effects of TSH withdrawal are not apparent until 1 day; 1 week is required to reduce I- uptake to a minimal level. The readdition of TSH leads to a return of the I--concentrating ability after a latency of 12-24 h. The reappearance of I- uptake induced by TSH is mimicked by (Bu)2cAMP and agents that elevate intracellular cAMP levels in these cells, such as forskolin, cholera toxin, and a Graves' disease serum. The appearance of I- uptake after TSH occurs 12 h after the appearance of TSH-induced [35S]methionine incorporation. Cycloheximide blocks both the TSH- and (Bu)2cAMP-induced increases in methionine incorporation and I- uptake to the same extent and in an identical concentration-dependent manner. TSH-induced [35S]methionine incorporation is associated with increased radiolabeling of several specific proteins, as revealed by gel electrophoresis; none, however, is radiolabeled coincident in time with the appearance of TSH-induced I- uptake. Several proteins whose apparent synthesis is induced by TSH also exhibit TSH-dependent phosphorylation.

This article has been cited by other articles:

				M. S. Fenton, K. M. Marion, and J. M. Hershman Identification of Cyclic Adenosine 3',5'-Monophosphate Response Element Modulator as an Activator of the Human Sodium/Iodide Symporter Upstream Enhancer Endocrinology, May 1, 2008; 149(5): 2592 - 2606. [Abstract] [Full Text] [PDF]

				D. D Vadysirisack, A. Venkateswaran, Z. Zhang, and S. M Jhiang MEK signaling modulates sodium iodide symporter at multiple levels and in a paradoxical manner Endocr. Relat. Cancer, June 1, 2007; 14(2): 421 - 432. [Abstract] [Full Text] [PDF]

				G. Riesco-Eizaguirre and P. Santisteban A perspective view of sodium iodide symporter research and its clinical implications. Eur. J. Endocrinol., October 1, 2006; 155(4): 495 - 512. [Abstract] [Full Text] [PDF]

				T Kogai, K Taki, and G A Brent Enhancement of sodium/iodide symporter expression in thyroid and breast cancer. Endocr. Relat. Cancer, September 1, 2006; 13(3): 797 - 826. [Abstract] [Full Text] [PDF]

				O. Dohan, A. De la Vieja, and N. Carrasco Hydrocortisone and Purinergic Signaling Stimulate Sodium/Iodide Symporter (NIS)-Mediated Iodide Transport in Breast Cancer Cells Mol. Endocrinol., May 1, 2006; 20(5): 1121 - 1137. [Abstract] [Full Text] [PDF]

				C. Laezza, M. Notarnicola, M. G. Caruso, C. Messa, M. Macchia, S. Bertini, F. Minutolo, G. Portella, L. Fiorentino, S. Stingo, et al. N6-isopentenyladenosine arrests tumor cell proliferation by inhibiting farnesyl diphosphate synthase and protein prenylation FASEB J, March 1, 2006; 20(3): 412 - 418. [Abstract] [Full Text] [PDF]

				S. Pena, S. Arum, M. Cross, B. Magnani, E. N. Pearce, M. E. Oates, and L. E. Braverman 123I Thyroid Uptake and Thyroid Size at 24, 48, and 72 Hours after the Administration of Recombinant Human Thyroid-Stimulating Hormone to Normal Volunteers J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 506 - 510. [Abstract] [Full Text] [PDF]

				N. Caraccio, R. Giannini, S. Cuccato, P. Faviana, P. Berti, D. Galleri, A. Dardano, F. Basolo, E. Ferrannini, and F. Monzani Type I Interferons Modulate the Expression of Thyroid Peroxidase, Sodium/Iodide Symporter, and Thyroglobulin Genes in Primary Human Thyrocyte Cultures J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1156 - 1162. [Abstract] [Full Text] [PDF]

				M. De Felice, M. P. Postiglione, and R. Di Lauro Minireview: Thyrotropin Receptor Signaling in Development and Differentiation of the Thyroid Gland: Insights from Mouse Models and Human Diseases Endocrinology, September 1, 2004; 145(9): 4062 - 4067. [Full Text] [PDF]

				A. Fanelli, E. F. Grollman, D. Wang, and N. J. Philp MCT1 and its accessory protein CD147 are differentially regulated by TSH in rat thyroid cells Am J Physiol Endocrinol Metab, December 1, 2003; 285(6): E1223 - E1229. [Abstract] [Full Text] [PDF]

				H. Kakinuma, E. R. Bergert, C. Spitzweg, J. C. Cheville, M. M. Lieber, and J. C. Morris Probasin Promoter (ARR2PB)-Driven, Prostate-Specific Expression of the Human Sodium Iodide Symporter (h-NIS) for Targeted Radioiodine Therapy of Prostate Cancer Cancer Res., November 15, 2003; 63(22): 7840 - 7844. [Abstract] [Full Text] [PDF]

				A. Porcellini, S. Messina, G. De Gregorio, A. Feliciello, A. Carlucci, M. Barone, A. Picascia, A. De Blasi, and E. V. Avvedimento The Expression of the Thyroid-stimulating Hormone (TSH) Receptor and the cAMP-dependent Protein Kinase RII {beta} Regulatory Subunit Confers TSH-cAMP-dependent Growth to Mouse Fibroblasts J. Biol. Chem., October 17, 2003; 278(42): 40621 - 40630. [Abstract] [Full Text] [PDF]

				D. Fuhrer, M. D. Lewis, F. Alkhafaji, K. Starkey, R. Paschke, D. Wynford-Thomas, M. Eggo, and M. Ludgate Biological Activity of Activating Thyroid-Stimulating Hormone Receptor Mutants Depends on the Cellular Context Endocrinology, September 1, 2003; 144(9): 4018 - 4030. [Abstract] [Full Text] [PDF]

				R.-Y. Lin, A. Kubo, G. M. Keller, and T. F. Davies Committing Embryonic Stem Cells to Differentiate into Thyrocyte-Like Cells in Vitro Endocrinology, June 1, 2003; 144(6): 2644 - 2649. [Abstract] [Full Text] [PDF]

				O. Dohan, A. De la Vieja, V. Paroder, C. Riedel, M. Artani, M. Reed, C. S. Ginter, and N. Carrasco The Sodium/Iodide Symporter (NIS): Characterization, Regulation, and Medical Significance Endocr. Rev., February 1, 2003; 24(1): 48 - 77. [Abstract] [Full Text] [PDF]

				B. Garcia and P. Santisteban PI3K Is Involved in the IGF-I Inhibition of TSH-Induced Sodium/Iodide Symporter Gene Expression Mol. Endocrinol., February 1, 2002; 16(2): 342 - 352. [Abstract] [Full Text] [PDF]

				D. A. Huysmans, W.-A. Nieuwlaat, R. J. Erdtsieck, A. P. Schellekens, J. W. Bus, B. Bravenboer, and A. R. Hermus Administration of a Single Low Dose of Recombinant Human Thyrotropin Significantly Enhances Thyroid Radioiodide Uptake in Nontoxic Nodular Goiter J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3592 - 3596. [Abstract] [Full Text]

				A. De la Vieja, O. Dohan, O. Levy, and N. Carrasco Molecular Analysis of the Sodium/Iodide Symporter: Impact on Thyroid and Extrathyroid Pathophysiology Physiol Rev, July 1, 2000; 80(3): 1083 - 1105. [Abstract] [Full Text] [PDF]

				I. E. Royaux, K. Suzuki, A. Mori, R. Katoh, L. A. Everett, L. D. Kohn, and E. D. Green Pendrin, the Protein Encoded by the Pendred Syndrome Gene (PDS), Is an Apical Porter of Iodide in the Thyroid and Is Regulated by Thyroglobulin in FRTL-5 Cells Endocrinology, February 1, 2000; 141(2): 839 - 845. [Abstract] [Full Text] [PDF]

				T. W. Furlanetto, L. Q. Nguyen, and J. L. Jameson Estradiol Increases Proliferation and Down-Regulates the Sodium/Iodide Symporter Gene in FRTL-5 Cells Endocrinology, December 1, 1999; 140(12): 5705 - 5711. [Abstract] [Full Text]

				M. Ohno, M. Zannini, O. Levy, N. Carrasco, and R. di Lauro The Paired-Domain Transcription Factor Pax8 Binds to the Upstream Enhancer of the Rat Sodium/Iodide Symporter Gene and Participates in Both Thyroid-Specific and Cyclic-AMP-Dependent Transcription Mol. Cell. Biol., March 1, 1999; 19(3): 2051 - 2060. [Abstract] [Full Text] [PDF]

				C. Laezza, V. Di Marzo, and M. Bifulco v-K-ras leads to preferential farnesylation of p21ras in FRTL-5 cells: Multiple interference with the isoprenoid pathway PNAS, November 10, 1998; 95(23): 13646 - 13651. [Abstract] [Full Text] [PDF]

				T. Saito, T. Endo, A. Kawaguchi, M. Ikeda, M. Nakazato, T. Kogai, and T. Onaya Increased Expression of the Na+/I- Symporter in Cultured Human Thyroid Cells Exposed to Thyrotropin and in Graves' Thyroid Tissue J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3331 - 3336. [Abstract] [Full Text] [PDF]

				M. A. Zeiger, M. Saji, Y. Gusev, W. H. Westra, Y. Takiyama, W. C. Dooley, L. D. Kohn, and M. A. Levine Thyroid-Specific Expression of Cholera Toxin A1 Subunit Causes Thyroid Hyperplasia and Hyperthyroidism in Transgenic Mice Endocrinology, August 1, 1997; 138(8): 3133 - 3140. [Abstract] [Full Text] [PDF]

				A. Paire, F. Bernier-Valentin, S. Selmi-Ruby, and B. Rousset Characterization of the Rat Thyroid Iodide Transporter Using Anti-peptide Antibodies. RELATIONSHIP BETWEEN ITS EXPRESSION AND ACTIVITY J. Biol. Chem., July 18, 1997; 272(29): 18245 - 18249. [Abstract] [Full Text] [PDF]

				T. Kogai, T. Endo, T. Saito, A. Miyazaki, A. Kawaguchi, and T. Onaya Regulation by Thyroid-Stimulating Hormone of Sodium/Iodide Symporter Gene Expression and Protein Levels in FRTL-5 Cells Endocrinology, June 1, 1997; 138(6): 2227 - 2232. [Abstract] [Full Text] [PDF]

				B. Perillo, I. Tedesco, C. Laezza, M. Santillo, A. Romano, S. M. Aloj, and M. Bifulco Regulation of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Gene Expression in FRTL-5 Cells J. Biol. Chem., June 23, 1995; 270(25): 15237 - 15241. [Abstract] [Full Text] [PDF]

				A Gallo, E Benusiglio, I M Bonapace, A Feliciello, S Cassano, C Garbi, A M Musti, M E Gottesman, and E V Avvedimento v-ras and protein kinase C dedifferentiate thyroid cells by down-regulating nuclear cAMP-dependent protein kinase A. Genes & Dev., September 1, 1992; 6(9): 1621 - 1630. [Abstract] [PDF]

				V E Avvedimento, A M Musti, M Ueffing, S Obici, A Gallo, M Sanchez, D DeBrasi, and M E Gottesman Reversible inhibition of a thyroid-specific trans-acting factor by Ras. Genes & Dev., January 1, 1991; 5(1): 22 - 28. [Abstract] [PDF]

				C. Riedel, O. Levy, and N. Carrasco Post-transcriptional Regulation of the Sodium/Iodide Symporter by Thyrotropin J. Biol. Chem., June 8, 2001; 276(24): 21458 - 21463. [Abstract] [Full Text] [PDF]

				T. Kogai, J. J. Schultz, L. S. Johnson, M. Huang, and G. A. Brent Retinoic acid induces sodium/iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cancer cell line PNAS, July 18, 2000; 97(15): 8519 - 8524. [Abstract] [Full Text] [PDF]